AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM - Trial NCT06378632
Access comprehensive clinical trial information for NCT06378632 through Pure Global AI's free database. This phase not specified trial is sponsored by Cordio Medical and is currently Recruiting. The study focuses on Heart Failure. Target enrollment is 500 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Cordio Medical
Timeline & Enrollment
N/A
Feb 11, 2022
Dec 01, 2024
Primary Outcome
Heart Failure Events (HFEs)
Summary
Study Design:
 
 This is an international, multicenter, observational, non-interventional, prospective,
 blinded, single-arm, two-period study, to collect patient utterances that will be
 retrospectively analyzed to determine the sensitivity and UPNR of the HearO system.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06378632
Device Trial